Stocks performed poorly in 2022. The Nasdaq and Russell 2000 saw the biggest declines. The Dow held up reasonably well compared to its peers. The stock market couldn't resist giving investors a ...

With more and more mainstream models offering hybrid powertrains, consumers have a lot of options to choose from. The best hybrids and plug-in hybrids don't just provide better fuel economy than ...

Health care spending in the US grew 4.1 percent to reach $4.5 trillion in 2022, which was still a faster rate of growth than the increase of 3.2 percent in 2021 but was much slower than the rate of 10 ...

The IRC reached 32.9 million clients in countries affected by conflict or humanitarian crisis in fiscal year 2022. That includes treating more than 450,000 children for malnutrition and providing more ...

How we did this We conducted this study to better understand which voters cast ballots in the 2022 midterm elections and how they voted. We also wanted to compare how turnout and vote choices differed ...

American Trends Panel: Pew Research Center’s online probability survey panel, which consists of more than 12,000 adults who take two to three surveys each month. Some panelists have been participating ...

National health expenditures are projected to grow 5.4 percent, on average, over the course of 2022–31 and to account for roughly 20 percent of the economy by the end of that period. The insured share ...

For Transparency International, 2022 was a year of creating vital, lasting change around the world. We are a global movement with more than 100 independent national chapters and partners working ...

World Report 2022, Human Rights Watch’s 32nd annual review of human rights trends around the globe, reviews developments in more than 100 countries. In his introductory essay, Executive Director ...

The Chiefs finished the final chapter of the 2022 NFL season, but we all know there's never a dull stretch on the NFL calendar. Before the NFL combine is the appropriate time to take in everything we ...

Pfizer sold $37.8 billion of its Covid vaccine last year, a small increase of 3% compared with 2021 as demand for the shots slowed. Sales of Paxlovid, however, surged to $18.9 billion in 2022, which ...

For a time during the fourth quarter, it looked like help was on the way for investors after a brutal first three quarters of the year. But by the end of 2022, relief over a potential slowing in ...